Insider: Barnett Eva Renee Chief Financial Officer - Immunovant, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 396,774 | 0 | 396,774 |
| Value | $9,720,963.00 | $0.00 | $9,720,963.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 04/16/2025 | DDS | 2,993 | Direct | COM | $14.89 | $44,565.77 | 396,774 |
| 04/09/2025 | DDS | 7,013 | Direct | COM | $12.99 | $91,098.87 | 403,817 |
| 04/09/2025 | DDS | 4,050 | Direct | COM | $12.99 | $52,609.50 | 399,767 |
| 02/19/2025 | DDS | 2,814 | Direct | COM | $20.86 | $58,700.04 | 321,952 |
| 01/15/2025 | DDS | 109 | Direct | COM | $24.19 | $2,636.71 | 324,766 |
| 01/15/2025 | DDS | 2,189 | Direct | COM | $23.81 | $52,120.09 | 324,875 |
| 01/08/2025 | DDS | 4,105 | Direct | COM | $24.10 | $98,930.50 | 327,064 |
| 11/20/2024 | DDS | 4,174 | Direct | COM | $25.45 | $106,228.30 | 331,169 |
| 10/16/2024 | DDS | 3,271 | Direct | COM | $28.79 | $94,172.09 | 335,343 |
| 10/09/2024 | DDS | 5,162 | Direct | COM | $29.56 | $152,588.72 | 338,614 |
| 08/21/2024 | DDS | 3,619 | Direct | COM | $31.84 | $115,228.96 | 343,925 |
| 08/21/2024 | DDS | 149 | Direct | COM | $32.32 | $4,815.68 | 343,776 |
| 07/17/2024 | DDS | 2,939 | Direct | COM | $29.64 | $87,111.96 | 347,728 |
| 07/17/2024 | DDS | 184 | Direct | COM | $30.55 | $5,621.20 | 347,544 |
| 07/09/2024 | DDS | 4,747 | Direct | COM | $28.06 | $133,200.82 | 350,667 |
| 05/22/2024 | DDS | 4,042 | Direct | COM | $29.65 | $119,845.30 | 355,414 |
| 04/17/2024 | DDS | 9,479 | Direct | COM | $28.80 | $272,995.20 | 362,230 |
| 04/17/2024 | DDS | 2,774 | Direct | COM | $29.94 | $83,053.56 | 359,456 |
| 04/09/2024 | DDS | 3,689 | Direct | COM | $31.18 | $115,023.02 | 371,709 |
| 02/22/2024 | DDS | 2,930 | Direct | COM | $36.15 | $105,919.50 | 320,420 |
| 01/11/2024 | DDS | 2,681 | Direct | COM | $41.64 | $111,636.84 | 324,184 |
| 01/11/2024 | DDS | 834 | Direct | COM | $42.43 | $35,386.62 | 323,350 |
| 11/22/2023 | DDS | 3,901 | Direct | COM | $32.75 | $127,757.75 | 327,019 |
| 11/22/2023 | DDS | 154 | Direct | COM | $33.52 | $5,162.08 | 326,865 |
| 10/10/2023 | DDS | 4,557 | Direct | COM | $36.92 | $168,244.44 | 330,920 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research